Major hepatic resection for metachronous metastases from colon cancer.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMC 1250642)

Published in Ann Surg on February 01, 1985

Authors

B Cady, W V McDermott

Articles citing this

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery (1988) 3.47

Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg (1989) 2.79

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

Repeat hepatectomy for colorectal liver metastases. Ann Surg (1997) 1.99

Liver resection for metastatic colorectal cancer. Surgery (1986) 1.92

Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81

Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46

A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg (1997) 1.22

Hepatic resection of metastasis from colorectal carcinoma. Morbidity, mortality, and pattern of recurrence. Ann Surg (1989) 1.22

CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg (1985) 1.19

Hepatic resection in the elderly. Ann Surg (1990) 1.07

Repeat hepatic resections for metastatic colorectal cancer. Ann Surg (1994) 1.05

Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol (2011) 1.01

Extended resections of liver metastases from colorectal cancer. World J Surg (2007) 1.00

Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg (1997) 0.99

Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg (1988) 0.95

Interstitial laser hyperthermia: a new approach for treating liver metastases. Br J Cancer (1992) 0.95

Resection of liver metastases from a colorectal carcinoma does not benefit the patient. Ann R Coll Surg Engl (1990) 0.81

The effect of cryotherapy on the cremaster muscle microcirculation in vivo. Br J Cancer (1994) 0.80

Chance mechanisms affecting the burden of metastases. BMC Cancer (2005) 0.80

Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases. Int J Colorectal Dis (2009) 0.78

Liver Metastases. Curr Treat Options Gastroenterol (1999) 0.78

Prediction of surgical resectability in patients with hepatic colorectal metastases. Ann Surg (1994) 0.77

Review of general surgery 1985. Postgrad Med J (1986) 0.75

Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis. Korean J Hepatobiliary Pancreat Surg (2012) 0.75

Surgical resection for colorectal hepatic metastases. Bull N Y Acad Med (1990) 0.75

Articles cited by this

Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

Experience with 150 liver resections. Ann Surg (1983) 3.01

Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg (1976) 2.96

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Survival after liver resection for secondary tumors. Am J Surg (1978) 2.57

A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol (1976) 2.42

Major hepatic resections for metastatic colorectal cancer. Ann Surg (1980) 2.41

Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am J Surg (1980) 1.69

Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum (1983) 1.60

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49

Hepatic resection of metastatic colorectal carcinoma: a ten-year experience. Arch Surg (1982) 1.43

A summary of thirteen years' experience with the second look program. Surg Gynecol Obstet (1962) 1.31

Carcinoma of the colon with liver metastases. Operative indications and prognosis. Acta Chir Scand (1971) 1.24

Hepatic resection for metastatic cancer. Ann Surg (1984) 1.21

Pulmonary resection for metastatic neoplasms in the lung. Experience at the Massachusetts General Hospital. Am J Surg (1978) 1.15

Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase. Ann Surg (1981) 1.11

Extensive resections of isolated metastasis from carcinoma of the colon and rectum. Surg Gynecol Obstet (1982) 1.07

EXPERIMENTAL STUDIES OF FACTORS INFLUENCING THE DEVELOPMENT OF HEPATIC METASTASES. XIII. EFFECT OF HEPATIC TRAUMA IN PARABIOTIC PAIRS. Cancer Res (1963) 0.90

Articles by these authors

Use of primary breast carcinoma characteristics to predict lymph node metastases. Cancer (1997) 2.13

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer (2000) 2.11

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10

The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res (1997) 2.00

Gastric cancer. Contemporary aspects. Am J Surg (1977) 1.72

Changing aspects of gastric adenocarcinoma. N Engl J Med (1984) 1.72

Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg (1976) 1.61

Lymph node metastases. Indicators, but not governors of survival. Arch Surg (1984) 1.51

Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet (1970) 1.48

Treatment of gastric cancer. Surg Clin North Am (1976) 1.44

Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg (1988) 1.43

Pseudocyst of the pancreas complicating distal splenorenal shunt. A report of three cases with successful percutaneous drainage. Ann Surg (1981) 1.40

Caution urged with repeat sentinel lymph node biopsies. Ann Oncol (2002) 1.39

Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg (1989) 1.37

Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol (1990) 1.26

Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys (1989) 1.26

Role of the Cdc25A phosphatase in human breast cancer. J Clin Invest (2000) 1.25

Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology (1981) 1.24

Factors in the prognosis of gastric lymphoma. Cancer (1977) 1.23

Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery (1985) 1.23

Changes in clinical presentation and management of malignant melanoma. Cancer (1981) 1.22

Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg (1974) 1.22

Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg (1993) 1.19

Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg (1998) 1.17

A comparison of ink-directed and traditional whole-cavity re-excision for breast lumpectomy specimens with positive margins. Ann Surg Oncol (2001) 1.16

Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy: another editorial perspective. Ann Surg Oncol (1998) 1.16

Elective portasystemic shunts: morbidity and survival data. Ann Surg (1971) 1.15

Risk factor analysis in differentiated thyroid cancer. Cancer (1979) 1.14

Percutaneous transhepatic biliary drainage. Complications due to multiple duct obstructions. Ann Surg (1983) 1.11

The American Cancer Society challenge goals. How far can cancer rates decline in the U.S. by the year 2015? Cancer (1999) 1.11

Total mastectomy and partial axillary dissection. Surg Clin North Am (1973) 1.10

Large intrahepatic cysts and pseudocysts. Pitfalls in diagnosis and treatment. Am J Surg (1978) 1.10

1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg (1994) 1.09

Combined caval and portal hypertension with cirrhosis of the liver. A problem in management. Ann Surg (1973) 1.08

Comfrey herb tea and hepatic veno-occlusive disease. Lancet (1989) 1.08

Staging in thyroid carcinoma. Cancer (1998) 1.08

Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol (1987) 1.08

Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys (1986) 1.07

Epidermoid carcinoma of the gum. A 20-year survey. Cancer (1969) 1.06

Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg (1990) 1.06

Shifting proportions of gastric adenocarcinomas. Arch Surg (1994) 1.06

Postshunt encephalopathy. Surg Gynecol Obstet (1968) 1.04

Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol (1997) 1.01

The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer (1986) 1.01

Pancreas divisum. Results of surgical intervention. Am J Surg (1983) 1.01

Familial bilateral cancer of the breast. Ann Surg (1970) 1.00

Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology (1985) 0.99

Axillary dissection in the context of the biology of lymph node metastases. Am J Surg (2000) 0.99

Conservative surgery and radiotherapy for early breast cancer. Cancer (1990) 0.98

A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg (1991) 0.98

Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg (1987) 0.98

Surgical innovation and its evaluation. Science (1978) 0.98

Role of Hepatic Arterial Blood Flow and Hepatic Nerves on Renal Circulation and Function: I. Acute Studies in the Dog. Ann Surg (1965) 0.98

Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys (1997) 0.98

Natural history of primary and secondary tumors of the liver. Semin Oncol (1983) 0.98

Proceedings: Changing patterns of colorectal carcinoma. Cancer (1974) 0.98

Cost of smoking. N Engl J Med (1983) 0.97

Surgical resection of intrahepatic bile duct cancer. Am J Surg (1969) 0.96

Contemporary treatment of malignant melanoma. Am J Surg (1975) 0.96

Insurance coverage of patients with breast cancer in the 1991 commission on cancer patient care evaluation study. Ann Surg Oncol (1994) 0.96

Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg (1986) 0.95

Effect of increasing outflow occlusion on the rate and composition of ascites formation by the isolated perfused procine liver. Surg Forum (1965) 0.95

Carcinomatous versus radiation-induced brachial plexus neuropathy in breast cancer. Cancer (1978) 0.94

Evaluation of the hemodynamics of portal hypertension in the selection of patients for shunt surgery. Ann Surg (1972) 0.94

Elective hepatic resection. Am J Surg (1966) 0.94

Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys (1997) 0.93

Technical considerations in a gastric bypass operation for morbid obesity. Surg Gynecol Obstet (1977) 0.93

Parietal cell vagotomy for intractable and obstructing duodenal ulcer. Am J Surg (1981) 0.93

Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monogr (1992) 0.93

Lactulose treatment of hepatic encephalopathy in outpatients. Arch Surg (1971) 0.93

Usefulness and technique of axillary dissection in primary breast cancer. J Clin Oncol (1986) 0.93

Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report. Cancer (1978) 0.92

Regeneration and maintenance of integrity of canine liver. The role of arterial, portal, and systemic venous blood. Arch Surg (1970) 0.92

Elective hepatic resection. Am J Surg (1979) 0.92

Surgery of thyroid cancer. World J Surg (1981) 0.91

Ectopic pelvic spleen. Arch Surg (1976) 0.91

The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg (1985) 0.91

Techniques of obtaining and preparing the porcine liver for experimental and clinical temporary ex vivo perfusion. J Surg Res (1966) 0.91

The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer (1994) 0.91

Budd-Chiari syndrome. Historical and clinical review with an analysis of surgical corrective procedures. Am J Surg (1984) 0.90

Conservative surgery and radiation therapy for early breast cancer: results, controversies, and unsolved problems. Semin Oncol (1986) 0.89

Massive hepatic resection in the treatment of severe liver trauma. Am J Surg (1969) 0.88

Effect of heparin, arvin, liver perfusion, and heterologous antiplatelet serum on rejection of pig kidney by dog. Transplant Proc (1971) 0.88

Clinical problems in follow-up of patients after conservative surgery and radiotherapy. Surg Clin North Am (1990) 0.88

Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience. Surgery (1989) 0.88

Controlling tobacco use. N Engl J Med (2001) 0.87

Preoperative radiation. Surg Gynecol Obstet (1968) 0.87

Hepatic arterial patency and complications after catheterization for infusion chemotherapy. Ann Surg (1973) 0.87

Repair of massive abdominal wall defects. Combined use of pneumoperitoneum and Marlex mesh. Surg Clin North Am (1976) 0.86

Non-epidermoid cancer of the larynx. Ann Surg (1968) 0.86

Pathologic prognostic factors for patients with breast carcinoma. Which factors are important. Surg Oncol Clin N Am (1997) 0.86

Subselective angiography in localizing insulinomas of the pancreas. AJR Am J Roentgenol (1977) 0.86

Long-term results in portarenal transposition in dogs. Surgery (1968) 0.86

Society of Gastrointestinal Radiologists Roscoe E. Miller Award. Monitoring hepatic cryosurgery with sonography. AJR Am J Roentgenol (1986) 0.86

Intraoperative ultrasound imaging of the liver at the time of colorectal cancer resection. Arch Surg (1994) 0.86

Biologic and clinical significance of lymphadenectomy. Surg Clin North Am (2000) 0.85